Patients May Be Modifying Meds Due to Trouble Swallowing

This article originally appeared here.
Share this content:
Patients May Be Modifying Meds Due to Trouble Swallowing
Patients May Be Modifying Meds Due to Trouble Swallowing

THURSDAY, April 2, 2015 (HealthDay News) -- Some patients experience difficulties swallowing and modify medication dosage forms, without necessarily consulting health professionals, according to research published in the March issue of the Journal of Pharmacy Practice and Research.

Esther T.L. Lau, Ph.D., from the Queensland University of Technology in Brisbane, Australia, and colleagues estimated the prevalence of swallowing difficulties and medication dosage form modification among community pharmacy consumers. Three hundred sixty-nine consumers were recruited from five community pharmacies and invited to participate in a structured interview.

The researchers found that 16.5 percent of participants reported experiencing difficulties in swallowing, and 10.6 percent reported modifying medication dosage forms. About half of those surveyed (44.2 percent) thought there would be no issues with medication dosage form modification. Regardless of their thoughts about issues associated with these practices, some consumers reported that they would not seek advice from health professionals on experiencing swallowing problems and/or before modifying their medication dosage forms.

"Some consumers appeared to be accustomed to modifying medication dosage forms, even when there was no apparent or obvious need. People were also reluctant to seek advice from health professionals regarding swallowing difficulties, or modifying medication dosage forms," the authors write. "Health professionals must be assertive in educating consumers about swallowing problems, and medication dosage form modification."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths